Advanced search
1 file | 1.13 MB

Metabolic fingerprinting reveals a novel candidate biomarker for prednisolone treatment in cattle

(2016) METABOLOMICS. 12(1).
Author
Organization
Abstract
The use of glucocorticoids as growth promoters for meat-producing animals is strictly regulated within the European Union. However, in the past few years, a higher frequency of non-compliant bovine urine samples for prednisolone has been noticed, which could not be directly related to fraudulent use of prednisolone. As such, questions have risen about the origin of this compound. Unfortunately, at present, no decisive strategy has been established to discriminate between endogenous and exogenous prednisolone. In this study, an untargeted metabolomics strategy, based on Orbitrap and QqTOF mass spectrometry, was deployed to reveal urinary biomarkers, which are indicative for the exogenous administration of the synthetic glucocorticoid prednisolone. For this purpose, prednisolone was administered intramuscularly and per os to 12 bovines and a total of 2700 urine samples were collected before, during and after treatment. Multivariate statistical data analysis (i.e. OPLS-DA) revealed four differentiating metabolites that allowed discrimination between urine samples collected before and during prednisolone administration. None of these compounds were present in urine containing endogenous prednisolone, of which the formation was induced by the administration of a synthetic analogue of adrenocorticotropic hormone. Only one metabolite was retained as a highly suitable biomarker during growth-promoting and therapeutic prednisolone treatment, with 93.4 % sensitivity and 96.3 % specificity. Besides, this compound could be detected up to 4 days after a single therapeutic per os prednisolone administration. Based on accurate mass, isotope pattern, and MS/MS spectra, this compound was putatively annotated and is suggested as an actionable biomarker for exogenous prednisolone administration.
Keywords
Prednisolone, Metabolomics, Biomarker, Bovine urine, In vivo, UHPLC-HRMS, CHROMATOGRAPHY-MASS SPECTROMETRY, BOVINE URINE, DRUG DEVELOPMENT, VALIDATION, PERFORMANCE, MS, SPECIFICITY, SENSITIVITY, ORIGIN, CORTICOSTEROIDS

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 1.13 MB

Citation

Please use this url to cite or link to this publication:

Chicago
De Clercq, Nathalie, Julie Vanden Bussche, Lieven Van Meulebroek, Siska Croubels, Philippe Delahaut, Dieter Buyst, José Martins, Jianru Stahl-Zeng, and Lynn Vanhaecke. 2016. “Metabolic Fingerprinting Reveals a Novel Candidate Biomarker for Prednisolone Treatment in Cattle.” Metabolomics 12 (1).
APA
De Clercq, Nathalie, Vanden Bussche, J., Van Meulebroek, L., Croubels, S., Delahaut, P., Buyst, D., Martins, J., et al. (2016). Metabolic fingerprinting reveals a novel candidate biomarker for prednisolone treatment in cattle. METABOLOMICS, 12(1).
Vancouver
1.
De Clercq N, Vanden Bussche J, Van Meulebroek L, Croubels S, Delahaut P, Buyst D, et al. Metabolic fingerprinting reveals a novel candidate biomarker for prednisolone treatment in cattle. METABOLOMICS. 2016;12(1).
MLA
De Clercq, Nathalie, Julie Vanden Bussche, Lieven Van Meulebroek, et al. “Metabolic Fingerprinting Reveals a Novel Candidate Biomarker for Prednisolone Treatment in Cattle.” METABOLOMICS 12.1 (2016): n. pag. Print.
@article{6995722,
  abstract     = {The use of glucocorticoids as growth promoters for meat-producing animals is strictly regulated within the European Union. However, in the past few years, a higher frequency of non-compliant bovine urine samples for prednisolone has been noticed, which could not be directly related to fraudulent use of prednisolone. As such, questions have risen about the origin of this compound. Unfortunately, at present, no decisive strategy has been established to discriminate between endogenous and exogenous prednisolone. In this study, an untargeted metabolomics strategy, based on Orbitrap and QqTOF mass spectrometry, was deployed to reveal urinary biomarkers, which are indicative for the exogenous administration of the synthetic glucocorticoid prednisolone. For this purpose, prednisolone was administered intramuscularly and per os to 12 bovines and a total of 2700 urine samples were collected before, during and after treatment. Multivariate statistical data analysis (i.e. OPLS-DA) revealed four differentiating metabolites that allowed discrimination between urine samples collected before and during prednisolone administration. None of these compounds were present in urine containing endogenous prednisolone, of which the formation was induced by the administration of a synthetic analogue of adrenocorticotropic hormone. Only one metabolite was retained as a highly suitable biomarker during growth-promoting and therapeutic prednisolone treatment, with 93.4 \% sensitivity and 96.3 \% specificity. Besides, this compound could be detected up to 4 days after a single therapeutic per os prednisolone administration. Based on accurate mass, isotope pattern, and MS/MS spectra, this compound was putatively annotated and is suggested as an actionable biomarker for exogenous prednisolone administration.},
  articleno    = {1},
  author       = {De Clercq, Nathalie and Vanden Bussche, Julie and Van Meulebroek, Lieven and Croubels, Siska and Delahaut, Philippe and Buyst, Dieter and Martins, Jos{\'e} and Stahl-Zeng, Jianru and Vanhaecke, Lynn},
  issn         = {1573-3882},
  journal      = {METABOLOMICS},
  keyword      = {Prednisolone,Metabolomics,Biomarker,Bovine urine,In vivo,UHPLC-HRMS,CHROMATOGRAPHY-MASS SPECTROMETRY,BOVINE URINE,DRUG DEVELOPMENT,VALIDATION,PERFORMANCE,MS,SPECIFICITY,SENSITIVITY,ORIGIN,CORTICOSTEROIDS},
  language     = {eng},
  number       = {1},
  pages        = {14},
  title        = {Metabolic fingerprinting reveals a novel candidate biomarker for prednisolone treatment in cattle},
  url          = {http://dx.doi.org/10.1007/s11306-015-0887-3},
  volume       = {12},
  year         = {2016},
}

Altmetric
View in Altmetric
Web of Science
Times cited: